The latest price target for Cargo Therapeutics (NASDAQ:CRGX) was reported by Truist Securities on January 30, 2025. The analyst firm set a price target for $7.00 expecting CRGX to rise to within 12 months (a possible 112.82% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Cargo Therapeutics (NASDAQ:CRGX) was provided by Truist Securities, and Cargo Therapeutics downgraded their hold rating.

There is no last upgrade for Cargo Therapeutics

The last downgrade for Cargo Therapeutics Inc happened on January 30, 2025 when Truist Securities changed their price target from $32 to $7 for Cargo Therapeutics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cargo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cargo Therapeutics was filed on January 30, 2025 so you should expect the next rating to be made available sometime around January 30, 2026.

While ratings are subjective and will change, the latest Cargo Therapeutics (CRGX) rating was a downgraded with a price target of $32.00 to $7.00. The current price Cargo Therapeutics (CRGX) is trading at is $3.29, which is out of the analyst’s predicted range.